ACR Convergence 2025| Video: Rheuminations on Milestones & Ageism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: fracture

Serum IGF-1 Tied to Fracture Risk in Elderly Women

David Douglas  |  September 14, 2015

NEW YORK (Reuters Health)—A Dutch study confirms that reduced serum levels of insulin-like growth factor-1 (IGF-1) are associated with increased fracture risk in elderly women, but not men. In an Aug. 31 online paper in the Journal of Clinical Endocrinology & Metabolism, Dr. N.C. van Varsseveld, of VU University Medical Center, Amsterdam, and colleagues noted that…

Filed under:ConditionsOsteoarthritis and Bone Disorders Tagged with:Fractureshiphip fracturehip fracture riskWomen

Growth Hormone Reduces Fractures in Women with Osteoporosis

Will Boggs, MD  |  September 4, 2015

NEW YORK (Reuters Health)—Growth hormone is associated with a decrease in fractures in women with postmenopausal osteoporosis even a decade after treatment ceases, researchers from Sweden report. “We were surprised and pleased to find that the patients had a reduced risk of fracture so many years after the growth hormone treatment was ceased,” Dr. Emily…

Filed under:ConditionsOsteoarthritis and Bone Disorders Tagged with:Growth HormoneOsteoporosispostmenopauseWomen

Abaloparatide-SC May Reduce Fractures for Osteoporosis & New FDA Safety Website

Michele B. Kaufman, PharmD, BCGP  |  July 22, 2015

In a 25 month Phase 3 trial, abaloparatide-SC reduced the risk of new fractures in patients suffering from postmenopausal osteoporosis. Plus, the FDA launches a new drug safety website.

Filed under:ConditionsDrug UpdatesOsteoarthritis and Bone Disorders Tagged with:abaloparatideFDAFracturesOsteoporosisosteoporosis treatmentsREMS

2014 ACR/ARHP Annual Meeting: Bone Fracture Concerns in Children

Susan Bernstein  |  April 1, 2015

Recognizing, reducing risk of bone fractures in pediatric patients with rheumatic disease, taking glucocorticoid therapy

Filed under:ConditionsMeeting ReportsOsteoarthritis and Bone DisordersPediatric Conditions Tagged with:ACR/ARHP Annual MeetingBernsteinChildrenFracturesglucocorticoidGlucocorticoid-Induced OsteoporosisOsteoporosispatient carePediatricRheumatic Diseasetherapy

Atypical Fractures Associated with Bisphosphonates

Michele B. Kaufman, PharmD, BCGP  |  November 1, 2014

Plus, FX006, odanacatib and other rheumatology drug news, safety updates

Filed under:ConditionsDrug UpdatesOsteoarthritis and Bone DisordersPain SyndromesSoft Tissue Pain Tagged with:bisphosphonatesdrugFibromyalgiaFracturesFX006KaufmanodanacatibOsteoporosisosteoporosis treatmentsrheumatologySafety

New Treatments Needed to Prevent Fractures in Osteoporosis

Ellen M. Field, MD, FACR, CCD  |  June 1, 2014

Current therapies target pathways of bone remodeling, but rheumatologists say a better understanding of the mechanisms of bone resorption, formation is needed to make an impact

Filed under:Biologics/DMARDsConditionsDrug UpdatesOsteoarthritis and Bone DisordersRheumatoid Arthritis Tagged with:Biologicsbone remodelingimagingOsteoporosispatient careRheumatoid arthritisrheumatologistUltrasound

Unexpected Benefits of Bisphosphonates after Hip Fracture

Cathleen Colon-Emeric, MD, MHS  |  February 3, 2012

Recent trials show this bisphosphonates can reduce subsequent hip fractures and mortality, while remaining cost effective.

Filed under:ConditionsOsteoarthritis and Bone Disorders Tagged with:anti-inflammatoryboneFractureship fractureOsteoporosispatient carerheumatologist

Glucocorticoids a Fracture Risk at Any Dose

Kathy Holliman  |  March 18, 2011

Updated recommendations advocate doing more to determine fracture risk and the need for preventive therapy

Filed under:ConditionsDrug UpdatesOsteoarthritis and Bone Disorders Tagged with:boneFracturesGlucocorticoid-Induced OsteoporosisGlucocorticoidsGuidelinesOsteoporosispatient careSteroids

Concrete Relief for Vertebral Fractures

Kurt Ullman  |  April 1, 2008

PVA reduces fracture pain—but is it overused?

Filed under:ConditionsOsteoarthritis and Bone Disorders Tagged with:Joint SurgeryOsteoporosisPainTreatmentvertebral fracture

New Research at ACR Convergence 2025 Demonstrates Impact of RISE Registry Data on Rheumatology Outcomes

From the College  |  October 19, 2025

New research presented at ACR Convergence 2025 highlights how the Rheumatology Informatics System for Effectiveness (RISE) Registry—the nation’s largest collection of electronic health record data from rheumatology practices—is driving transformative improvements in quality, safety and outcomes in patients with rheumatic and musculoskeletal diseases. Research studies reveal that participation in and engagement with RISE not only…

Filed under:ACR Convergence Tagged with:ACR Convergence 2025Rheumatology Informatics System for Effectiveness (RISE) Registry

  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 43
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences